164 related articles for article (PubMed ID: 3942001)
1. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma.
Tisell LE; Hansson G; Jansson S; Salander H
Surgery; 1986 Jan; 99(1):60-6. PubMed ID: 3942001
[TBL] [Abstract][Full Text] [Related]
2. Recent results of reoperative surgery in medullary carcinoma of the thyroid.
Tisell LE; Jansson S
Wien Klin Wochenschr; 1988 May; 100(11):347-8. PubMed ID: 3407193
[TBL] [Abstract][Full Text] [Related]
3. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of medullary carcinoma of the thyroid.
Block MA
Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
[TBL] [Abstract][Full Text] [Related]
5. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative high-dose calcium stimulation test in patients with sporadic medullary thyroid carcinoma is highly accurate in predicting lateral neck metastases.
De Crea C; Raffaelli M; Milano V; Carrozza C; Zuppi C; Bellantone R; Lombardi CP
Surgery; 2016 Jan; 159(1):70-6. PubMed ID: 26456123
[TBL] [Abstract][Full Text] [Related]
7. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
Schott M; Willenberg HS; Sagert C; Nguyen TB; Schinner S; Cohnen M; Cupisti K; Eisenberger CF; Knoefel WT; Scherbaum WA
Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
[TBL] [Abstract][Full Text] [Related]
8. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
[TBL] [Abstract][Full Text] [Related]
9. Postoperative pentagastrin-stimulated serum calcitonin concentrations in patients with medullary thyroid carcinoma: reoperations in patients with concentrations bordering the detection limit.
Meybier H; Schmidt-Gayk H; Buhr H; Raue F
Henry Ford Hosp Med J; 1989; 37(3-4):138-40. PubMed ID: 2576947
[TBL] [Abstract][Full Text] [Related]
10. Microsurgical neck dissection for occultly metastasizing medullary thyroid carcinoma. Three-year results.
Buhr HJ; Kallinowski F; Raue F; Frank-Raue K; Herfarth C
Cancer; 1993 Dec; 72(12):3685-93. PubMed ID: 8252485
[TBL] [Abstract][Full Text] [Related]
11. Medullary thyroid carcinoma and calcitonin.
Emmertsen K
Dan Med Bull; 1985 Mar; 32(1):1-28. PubMed ID: 2859145
[TBL] [Abstract][Full Text] [Related]
12. [One stage thyroidectomy and bilateral neck dissection for well-differentiated thyroid carcinoma].
Pan YF; Zhang XH; Ye GH; Lin BR; Chen XM; Jia XJ; Zhou SM; Wang OC
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):389-92. PubMed ID: 17045009
[TBL] [Abstract][Full Text] [Related]
13. Microsurgical lymph node dissection for metastatic asymptomatic C-cell carcinoma.
Buhr HJ; Kallinowski F; Raue F; Herfarth C
Henry Ford Hosp Med J; 1992; 40(3-4):268-70. PubMed ID: 1362421
[TBL] [Abstract][Full Text] [Related]
14. The value of intraoperative pentagastrin testing in medullary thyroid cancer.
Scheuba C; Bieglmayer C; Asari R; Kaczirek K; Izay B; Kaserer K; Niederle B
Surgery; 2007 Feb; 141(2):166-71; discussion 171-2. PubMed ID: 17263971
[TBL] [Abstract][Full Text] [Related]
15. Management of occult medullary thyroid carcinoma: evidenced only by serum calcitonin level elevations after apparently adequate neck operations.
Block MA; Jackson CE; Tashjian AH
Arch Surg; 1978 Apr; 113(4):368-72. PubMed ID: 637706
[TBL] [Abstract][Full Text] [Related]
16. Benefit-risk balance of reoperation for persistent medullary thyroid cancer.
Machens A; Dralle H
Ann Surg; 2013 Apr; 257(4):751-7. PubMed ID: 23023200
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of medullary carcinoma of the thyroid.
Tisell LE; Hansson G; Jansson S
Horm Metab Res Suppl; 1989; 21():29-31. PubMed ID: 2807153
[TBL] [Abstract][Full Text] [Related]
18. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
[TBL] [Abstract][Full Text] [Related]
19. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.
Kim MK; Mandel SH; Baloch Z; Livolsi VA; Langer JE; Didonato L; Fish S; Weber RS
Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1214-6. PubMed ID: 15492172
[TBL] [Abstract][Full Text] [Related]
20. [The concept of "microsurgical" technique in medullary thyroid carcinoma].
Mann B; Buhr HJ; Faulhaber J
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():720-3. PubMed ID: 9931710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
